Transcranial Direct Stimulation in Chronic Pelvic Pain
Status: | Completed |
---|---|
Conditions: | Healthy Studies, Women's Studies |
Therapuetic Areas: | Other, Reproductive |
Healthy: | No |
Age Range: | 18 - 64 |
Updated: | 3/16/2017 |
Start Date: | April 2010 |
End Date: | May 2013 |
Investigation and Treatment of Central Nervous System Dysfunction in Chronic Pelvic Pain.
The purpose of this study is to determine whether transcranial direct current stimulation
(tDCS) is effective in reducing pain in subjects with chronic pelvic pain. Our hypothesis is
that tDCS will decrease pain significantly when compared to sham stimulation.
(tDCS) is effective in reducing pain in subjects with chronic pelvic pain. Our hypothesis is
that tDCS will decrease pain significantly when compared to sham stimulation.
The study encompasses two experiments: The first one involves patients with chronic pain,
receiving 10 sessions of stimulation, active or sham (parallel design).
The second experiment involves involves healthy subjects, receiving active or sham tDCS over
the primary motor cortex (crossover design).
receiving 10 sessions of stimulation, active or sham (parallel design).
The second experiment involves involves healthy subjects, receiving active or sham tDCS over
the primary motor cortex (crossover design).
Inclusion Criteria:
1. Providing informed consent to participate in the study
2. 18 to 64 years old
3. Having symptoms of pelvic pain for more than 6 months with an average of 3 on a 0-10
VAS scale (for pelvic pain subjects only)
4. No history of or current genitourinary tuberculosis as self reported
5. No history of urethral cancer as self reported
6. No history or current bladder malignancy, high grade dysplasia or carcinoma in situ
as self reported
7. No occurrence of ovarian, vaginal or cervical cancer in the previous 3 years as self
reported
8. No current vaginal infection as self reported
9. No active herpes in previous 3 months as self reported
10. No antimicrobials for urinary tract infections in previous 3 months as self reported
11. Never treated with cyclophosphamide as self reported
12. No radiation cystitis as self reported
13. No neurogenic bladder dysfunction (due to a spinal cord injury, stroke, Parkinson's
disease, multiple sclerosis, spina bifida or diabetic cystopathy) as self reported
14. Absence of bladder, ureteral or urethral calculi for previous 3 months as self
reported
15. No urethritis for previous 3 months as self reported
16. No urethral dilatation, cystometrogram, bladder cystoscopy with full anesthesia or
bladder biopsy in previous 3 months as self reported
17. Must not be pregnant
18. Eligible to MRI according to MRI screening checklist
19. No contraindications to tDCS:
20. No history of alcohol or drug abuse within the past 6 months as self reported
21. No use of carbamazepine as self reported
22. Does not have severe depression (with a score of >30 in the Beck Depression
Inventory)
23. No history of neurological disorders as self reported
24. No history of unexplained fainting spells as self reported,
25. No history of head injury resulting in more than a momentary loss of consciousness as
self reported
26. Have had no neurosurgery as self reported
27. No history of psychological disorders as self reported
28. Must have the ability to feel pain as self reported
We found this trial at
1
site
Spaulding Rehabilitation Hospital At Spaulding Rehabiliation Hospital Boston, our unique approach to therapy includes use...
Click here to add this to my saved trials